GlassScriptPhysician profile
Jonathan William Garcell
NPI 1801421292
$1,815.74
in general payments reported to CMS, 2019-2025
8 companies · $368 in 2025
The $368 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $444 · 2023: $371 · 2024: $509 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,246.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $714.98 | 2021-2025 | |
| Amgen INC. | $371.46 | 2023-2025 | Nplate, Imdelltra (Amg757) |
| Recordati_rare_diseases_inc. | $339.80 | 2024 | Sylvant |
| Sanofi-Aventis U.S. LLC | $123.88 | 2023 | |
| Xeris Pharmaceuticals, INC. | $106.94 | 2025 | Recorlev |
| Rigel Pharmaceuticals, INC. | $102.87 | 2022 | |
| Adaptive Biotechnologies Corporation | $28.83 | 2024 | Clonoseq |
| Merck Sharp & Dohme LLC | $26.98 | 2025 | Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Garcell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.